Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

A pill designed to prevent unintended pregnancy and birth defects is moving closer to commercial reality following a Food and Drug Administration (FDA) advisory committee’s unanimous vote to back such a combination product.

FDA panel gives nod to adding folic acid to OC